KR20020007371A - Ｔ 세포 중재된 면역의 개선 - Google Patents

Ｔ 세포 중재된 면역의 개선 Download PDF

Info

Publication number
KR20020007371A
KR20020007371A KR1020017013148A KR20017013148A KR20020007371A KR 20020007371 A KR20020007371 A KR 20020007371A KR 1020017013148 A KR1020017013148 A KR 1020017013148A KR 20017013148 A KR20017013148 A KR 20017013148A KR 20020007371 A KR20020007371 A KR 20020007371A
Authority
KR
South Korea
Prior art keywords
cells
thymus
cell
subject
mice
Prior art date
Application number
KR1020017013148A
Other languages
English (en)
Korean (ko)
Inventor
보이드리차드렌녹스
Original Assignee
다랄 피터 엘이피.
모나쉬 유니버시티
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다랄 피터 엘이피., 모나쉬 유니버시티 filed Critical 다랄 피터 엘이피.
Publication of KR20020007371A publication Critical patent/KR20020007371A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020017013148A 1999-04-15 2000-04-17 Ｔ 세포 중재된 면역의 개선 KR20020007371A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP9778 1999-04-15
AUPP9778A AUPP977899A0 (en) 1999-04-15 1999-04-15 Improvement of t cell mediated immunity
PCT/AU2000/000329 WO2000062657A2 (en) 1999-04-15 2000-04-17 Improvement of t cell mediated immunity

Publications (1)

Publication Number Publication Date
KR20020007371A true KR20020007371A (ko) 2002-01-26

Family

ID=3813977

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017013148A KR20020007371A (ko) 1999-04-15 2000-04-17 Ｔ 세포 중재된 면역의 개선

Country Status (11)

Country Link
EP (1) EP1191975A4 (zh)
JP (1) JP2002542174A (zh)
KR (1) KR20020007371A (zh)
CN (1) CN100376288C (zh)
AU (2) AUPP977899A0 (zh)
BR (1) BR0009712A (zh)
CA (1) CA2370296A1 (zh)
HK (1) HK1046249A1 (zh)
NZ (1) NZ514975A (zh)
WO (1) WO2000062657A2 (zh)
ZA (1) ZA200108451B (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086000A1 (en) * 1999-04-15 2002-07-04 Richard Boyd Stimulation of thymus for vaccination development
US20020071829A1 (en) * 1999-04-15 2002-06-13 Richard Boyd Normalization of defective T cell responsiveness through manipulation of thymic regeneration
US20040258672A1 (en) * 1999-04-15 2004-12-23 Monash University Graft acceptance through manipulation of thymic regeneration
AUPR074500A0 (en) * 2000-10-13 2000-11-09 Monash University Treatment of t cell disorders
AU2002216320C1 (en) * 2000-10-13 2008-04-03 Norwood Immunology Ltd Hematopoietic stem cell gene therapy
BR0114642A (pt) * 2000-10-13 2004-01-20 Univ Monash Prevenção de doenças através da reativação do timo
AU1632002A (en) * 2000-10-13 2002-04-22 Richard Boyd Hematopoietic stem cell gene therapy
AU2002225245C1 (en) * 2000-10-13 2008-07-17 Norwood Immunology Ltd Improvement of graft acceptance through manipulation of thymic regeneration
WO2002030256A2 (en) * 2000-10-13 2002-04-18 Monash University Diagnostic indicator of thymic function
NZ525829A (en) * 2000-10-13 2005-04-29 Norwood Immunology Ltd Improvement of graft acceptance by T cell ablation, areactivating the thymus and adminstrating hematopoietic or epithelial stem cells or progenitor cells
AU2002216323C1 (en) * 2000-10-13 2008-05-29 Norwood Immunology Ltd Disease prevention by reactivation of the thymus
AU2001295270B2 (en) * 2000-10-13 2007-08-09 Norwood Immunology Ltd Treatment of T cell disorders
IL147138A0 (en) * 2001-12-17 2002-08-14 Yeda Res & Dev Methods of and pharmaceutical compositions for modulating cell adhesion, migration and extravasation
EP1620126A4 (en) * 2003-04-18 2007-07-04 Norwood Immunology Ltd PREVENTION OF DISEASES AND VACCINATION BEFORE THYMUS REACTIVATION
RU2010114017A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Терапевтическое применение натрийуретического пептида в-типа и гормона роста человека 1-43
BR112013033988B1 (pt) * 2011-07-01 2021-10-19 Beckman Coulter, Inc. Métodos de identificação e isolamento de uma ou mais populações de células t regulatórias imunossupressoras
CN103235135B (zh) * 2013-04-26 2015-02-04 史其新 一种用于表征外周调节性t细胞抑制活性的特征细胞群的检测方法及其应用
TWI820753B (zh) * 2016-11-11 2023-11-01 美商生命科學公司 使用人類間葉幹細胞以實現細胞性及體液性免疫的方法
US11819520B2 (en) 2018-02-23 2023-11-21 Duke University Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants
CA3089593A1 (en) 2018-02-23 2019-08-29 Mary Louise MARKERT Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01500663A (ja) * 1986-08-18 1989-03-09 バンジ・（オーストラリア）・プロプライアタリー・リミテッド 動物の生殖機能の調節
AU634379B2 (en) * 1991-04-29 1993-02-18 Csl Limited Recombinant immunocastration vaccine

Also Published As

Publication number Publication date
AU779067B2 (en) 2005-01-06
AUPP977899A0 (en) 1999-05-13
EP1191975A4 (en) 2005-05-25
JP2002542174A (ja) 2002-12-10
CA2370296A1 (en) 2000-10-26
ZA200108451B (en) 2003-01-15
WO2000062657A3 (en) 2001-01-11
AU3797700A (en) 2000-11-02
WO2000062657A2 (en) 2000-10-26
CN100376288C (zh) 2008-03-26
HK1046249A1 (zh) 2003-01-03
NZ514975A (en) 2004-03-26
EP1191975A2 (en) 2002-04-03
CN1364093A (zh) 2002-08-14
BR0009712A (pt) 2002-04-30

Similar Documents

Publication Publication Date Title
KR20020007371A (ko) Ｔ 세포 중재된 면역의 개선
US20060188521A1 (en) Treatment of T cell disorders
CA2462758A1 (en) Diagnostic indicator of thymic function
US20040258672A1 (en) Graft acceptance through manipulation of thymic regeneration
US20020136704A1 (en) Diagnostic indicator of thymic function
US20060088512A1 (en) Treatment of T cell disorders
AU2001295270B2 (en) Treatment of T cell disorders
US20020119128A1 (en) Graft acceptance through manipulation of thymic regeneration
US20040265285A1 (en) Normalization of defective T cell responsiveness through manipulation of thymic regeneration
AU2001295270A1 (en) Treatment of T cell disorders
CA2462073A1 (en) Hematopoietic stem cell gene therapy
AU2002225245B2 (en) Improvement of graft acceptance through manipulation of thymic regeneration
US20040037816A1 (en) Graft acceptance through manipulation of thymic regeneration
CA2462671A1 (en) Normalization of defective t cell responsiveness through manipulation of thymic regeneration
US20050215479A1 (en) Diagnostic indicator of thymic function
US20040037817A1 (en) Normalization of defective T cell responsiveness through manipulation of thymic regeneration
US20020086003A1 (en) Stimulation of thymus for vaccination development
CA2462027A1 (en) Stimulation of thymus for vaccination development
AU2007202609A1 (en) Stimulation of thymus for vaccination development
ZA200303684B (en) Stimulation of thymus for vaccination development
AU2007202613A1 (en) Diagnostic indicator of thymic function

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
N231 Notification of change of applicant
E601 Decision to refuse application
J201 Request for trial against refusal decision
J801 Dismissal of trial

Free format text: REJECTION OF TRIAL FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20070705

Effective date: 20070913

Free format text: TRIAL NUMBER: 2007101007464; REJECTION OF TRIAL FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20070705

Effective date: 20070913